1995•PubMedRequires access

[Diphosphonates in the treatment of osteoporosis and in the prevention of associated fractures].

Marianna Gregorio, G. de Gregorio

Abstract

Diphosphonates are capable to increase vertebral bone mineral mass in postmenopausal osteoporosis. Because the risk of fractures is related to the reduction of bone mass, the positive effect of diphosphonates most probably produced a decrease in fracture rate. At present these drugs represent a rational option for the treatment of postmenopausal osteoporosis.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Diphosphonates, Medicine, Osteoporosis, Postmenopausal osteoporosis, Postmenopausal women, Bone mass, Reduction (mathematics), Dentistry